Contraceptive Devices Market Overview:
The latest report published by IMARC Group, titled, “Contraceptive Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027″, offers a comprehensive analysis of the industry, which comprises insights on the Contraceptive Devices Market Outlook. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global contraceptive devices market reached US$ 12.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.96% during 2022-2027. Contraceptive devices refer to birth control tools used to prevent pregnancies and sexually transmitted diseases (STDs). These devices are customized for both male and female users and comprise spermicides to chemically neutralize sperms. Condoms, diaphragms, sponges, cervical caps, vaginal rings, subdermal implants and intrauterine devices (IUD) are some of the commonly used contraceptive devices.
Global Contraceptive Devices Market Trends:
The rising prevalence of STDs, including chlamydia, hepatitis B, gonorrhea, trichomoniasis, HIV/AIDS, represents one of the significant factors strengthening the growth of the contraceptive devices market across the globe. Moreover, the growing consciousness among individuals about the available alternatives for minimizing unexpected pregnancies is catalyzing the demand for contraceptive devices. Furthermore, leading manufacturers are investing in research and development (R&D) activities to develop product variants with higher efficacy and minimal side effects. This, in confluence with the increasing inclination toward delayed pregnancies and rising healthcare expenditures of individuals, is anticipated to fuel the market growth.
Competitive Landscape with Key Players:
- Allergan Plc
- Bayer Healthcare
- Church & Dwight Co. Inc.
- Cooper Surgical Inc.
- Merck & Co.
- Mylan Laboratories
- Pfizer Inc.
- Reckitt Benckiser
- Teva Pharmaceutical Industries Ltd.
- The Female Health Company
Key Market Segmentation:
- Cervical Caps
- Vaginal Rings
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
|Base Year of the Analysis||2021|
|Segment Coverage||Device Type, End User, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Allergan plc, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Merck & Co., Mylan Inc., Pfizer Inc., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., and The Female Health Company|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499|
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|